Dataset Information


Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.

ABSTRACT: Geldanamycin derivatives are benzoquinone ansamycin antibiotics that bind to Hsp90 and alter its function. The alteration of Hsp90 activity limits some cellular hormonal responses by inhibiting nuclear receptors activation. The nuclear receptors activity, such as PPAR?, the mineralocorticoid and glucocorticoid receptors (MR and GR) play a critical role in the conversion of preadipocytes to mature adipocytes. Given the importance of these nuclear receptors for adipogenesis, we investigated the effects of geldanamycin analogues (GA) on adipocyte differentiation and function. We found that early exposure of preadipocyte cells to GA inhibited their conversion into mature adipocytes by inhibiting the adipogenic transcriptional program and lipid droplets accumulation. Furthermore, GA altered the adipokines secretion profile of mature adipocyte. The anti-adipogenic effect of GA was also confirmed in mice fed a high fat diet. Biochemical analysis revealed that anti-adipogenic effects of geldanamycin analogues may result from the simultaneous inhibition of MR, GR and PPAR? activity. Taken together, our observations lead us to propose Hsp90 as a potent target for drug development in the control of obesity and its related metabolic complications.

SUBMITTER: Desarzens S 

PROVIDER: S-EPMC3976389 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3824595 | BioStudies
1000-01-01 | S-EPMC5954194 | BioStudies
2010-01-01 | S-EPMC3006625 | BioStudies
2019-01-01 | S-EPMC6883588 | BioStudies
| GSE14004 | GEO
| GSE14004 | GEO
1000-01-01 | S-EPMC3449261 | BioStudies
2018-01-01 | S-EPMC6260163 | BioStudies
2009-01-29 | E-GEOD-14004 | ArrayExpress
1000-01-01 | S-EPMC4815986 | BioStudies